Among Older Women, DHEA May Attenuate Declines In BMD, Modestly Increase Fat-Free Mass Over 12 Months When Compared With Placebo,

Among older women, the adrenal steroid dehydroepiandrosterone [DHEA] may attenuate declines in bone mineral density [BMD] and modestly increase fat-free mass over 12 months when compared with placebo,” researchers concluded after analyzing “data from four single-site, double-blind, randomized controlled trials sponsored by the National Institute on Aging designed to assess the effects of DHEA sulfate therapy on BMD and body composition in adults aged 55 to 85 years not using sex hormone therapy (295 women).” The findings were published online in Clinical Endocrinology. https://www.healio.com/endocrinology/reproduction-androgen-disorders/news/in-the-journals/%7Bf5859c6e-c82a-42f5-a446-877b66d31626%7D/dhea-therapy-may-preserve-bone-muscle-mass-in-older-women